Czernin Johannes1, Herrmann Ken2. 1. Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California; and. 2. Department of Nuclear Medicine, Universitätsklinikum Essen, Essen, Germany kenhermann@uk-essen.de.
Authors: Roelof J Bennink; Mathias Prokop; Andor W J M Glaudemans; Liesbeth Peters-Bax; Jasper H Helthuis; Arthur Adams; Peter R Kornaat; Adriaan A Lammertsma; Lenka M Pereira Arias-Bouda Journal: J Nucl Med Date: 2021-07-16 Impact factor: 11.082